Glycomimetics Inc (GLYC) USD0.001

Sell:$0.25Buy:$0.28$0.01 (5.01%)

Prices delayed by at least 15 minutes
Sell:$0.25
Buy:$0.28
Change:$0.01 (5.01%)
Prices delayed by at least 15 minutes
Sell:$0.25
Buy:$0.28
Change:$0.01 (5.01%)
Prices delayed by at least 15 minutes

Company Information

About this company

GlycoMimetics, Inc. is a biotechnology company. The Company has no ongoing operations, is not performing any research and development, and is preserving cash until the contemplated merger and private placement. The Company was developing a pipeline of proprietary glycomimetics, which are small molecules that mimic the structure of carbohydrates involved in important biological processes, to inhibit disease-related functions of carbohydrates such as the roles they play in cancers and inflammation.

Key people

Bruce Johnson
Senior Vice President, Chief Commercial Officer
Chinmaya Rath
Senior Vice President, Chief Business Officer
Timothy R. Pearson
Independent Chairman of the Board
Patricia S. Andrews
Independent Director
Daniel M. Junius
Independent Director
Click to see more

Key facts

  • EPIC
    GLYC
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US38000Q1022
  • Market cap
    $16.88m
  • Employees
    4
  • Shares in issue
    64.51m
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.